Role of somatic cancer mutations in human protein lysine methyltransferases

2014 ◽  
Vol 1846 (2) ◽  
pp. 366-379 ◽  
Author(s):  
Srikanth Kudithipudi ◽  
Albert Jeltsch
2013 ◽  
Vol 16 (1) ◽  
pp. 70-82 ◽  
Author(s):  
Anastasia Spyropoulou ◽  
Antonios Gargalionis ◽  
Georgia Dalagiorgou ◽  
Christos Adamopoulos ◽  
Kostas A. Papavassiliou ◽  
...  

2016 ◽  
Vol 4 (3) ◽  
pp. 293-299 ◽  
Author(s):  
JIFU LI ◽  
SHUNQIN ZHU ◽  
XIAO-XUE KE ◽  
HONGJUAN CUI

2007 ◽  
Vol 282 (30) ◽  
pp. 21838-21847 ◽  
Author(s):  
Jennifer A. Gibbons ◽  
Lukasz Kozubowski ◽  
Kelly Tatchell ◽  
Shirish Shenolikar

2021 ◽  
Vol 18 (1-2) ◽  
pp. 44-57
Author(s):  
Y. O. Tabaliuk ◽  
L. A. Rybchenko ◽  
B. T. Klimuk ◽  
S. V. Klymenko

In the article there were looked some aspects of the knowledge regarding mutations in BRCA1 BRCA2 genes that have been accumulated since the first report on role of these genes in the development of breast and ovarian cancer. Most of them have practical worth related to the detection of mutations, as well as the prevention and treatment of associated ovarian cancer (the article focuses specifically on ovarian cancer, conditioned to relatively less amount of information on this pathology). There has been paid attention to the rational assignment of a genetic test on the presence of mutations in BRCA genes.Keywords: ovarian cancer, mutations in BRCA1 BRCA2 genes, screening of the presence mutations in BRCA1 BRCA2 genes.


2021 ◽  
Author(s):  
Nicole E. Bowen ◽  
Joshua Temple ◽  
Caitlin Shepard ◽  
Adrian Oo ◽  
Fidel Arizaga ◽  
...  

Biology ◽  
2021 ◽  
Vol 10 (7) ◽  
pp. 640
Author(s):  
Nataša Pavlović ◽  
Femke Heindryckx

Endoplasmic reticulum (ER) stress and actors of unfolded protein response (UPR) have emerged as key hallmarks of hepatocarcinogenesis. Numerous reports have shown that the main actors in the UPR pathways are upregulated in HCC and contribute to the different facets of tumor initiation and disease progression. Furthermore, ER-stress inducers and inhibitors have shown success in preclinical HCC models. Despite the mounting evidence of the UPR’s involvement in HCC pathogenesis, it remains unclear how ER-stress components can be used safely and effectively as therapeutic targets or predictive biomarkers for HCC patients. In an effort to add a clinical context to these findings and explore the translational potential of ER-stress in HCC, we performed a systematic overview of UPR-associated proteins as predictive biomarkers in HCC by mining the Human Protein Atlas database. Aside from evaluating the prognostic value of these markers in HCC, we discussed their expression in relation to patient age, sex, ethnicity, disease stage, and tissue localization. We thereby identified 44 UPR-associated proteins as unfavorable prognostic markers in HCC. The expression of these markers was found to be higher in tumors compared to the stroma of the hepatic HCC patient tissues.


Sign in / Sign up

Export Citation Format

Share Document